TRPM7 and myalgic encephalomeyelitis/chronic fatigue syndrome: Inhibition of TRPM7 using NS8593 (6 μM) did not produce a significant difference in the slope of response between the ME/CFS (22.48 ± 1.22) and HC (19.05 ± 1.36) cohorts.